PPARA and hydrops fetalis: As PPAR activators can rescue HF through metabolic alterations and are being pursued as therapeutics [284,285], PPAR activators have different and sometimes detrimental outcomes in noncardiac tissues and may induce tumorigenesis [286,287,288,289].